Valuation (29%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -9.01 | 6.81 |
PEG Ratio (TTM) | 0.00 | -0.79 |
P/S Ratio (TTM) | 6.85 | 0.74 |
P/B Ratio (TTM) | 0.80 | 1.15 |
P/FCF Ratio (TTM) | -60.75 | 13.45 |
Price to 5YR AVG Earnings Ratio | N/A | 6.79 |
Price to 5YR AVG FCF Ratio | N/A | 7.18 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.61% | 5.50% |
ROE (TTM) | -8.78% | 8.55% |
Net Profit Margin (TTM) | -13.06% | 5.55% |
ROIC 5YR AVG | N/A | 19.37% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -722.23% | 13.85% | N/A |
Revenue | -15.50% | 36.02% | N/A |
Net Income | -744.56% | 13.42% | N/A |
Cash Flow | 7.31% | 38.18% | N/A |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.44 | 2.45 |
Quick Ratio (TTM) | 1.16 | 1.40 |
D/E Ratio (TTM) | 0.50 | 0.33 |
Interest Coverage (TTM) | N/A | 32.30 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 5.70 | 3.36 |
LTL to 5YR AVG FCF | N/A | 2.80 |
Shares Outstanding Growth 5YR AVG | N/A | -3.62% |